Bruno García del Blanco

Showing 1-8 of 8 articles

Thin- versus thick-strut polymer-free biolimus-eluting stents: the BioFreedom QCA randomised trial

Sabaté M, Okkels Jensen L, Tilsted H, Moreno R, García del Blanco B, Macaya C, Pérez de Prado A, Cequier A, Pérez-Fuentes P, Schütte D, Costa R, Stoll H, Flensted Lassen J

June 25, 2021 | 10.4244/EIJ-D-20-01162

Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction: vascular healing outcomes from the MAGSTEMI trial

Gomez-Lara J, Ortega-Paz L, Brugaletta S, Cuesta J, Romani S, Serra A, Salinas P, García del Blanco B, Goicolea J, Hernandez-Antolín R, Antuña P, Romaguera R, Regueiro A, Rivero F, Cequier A, Alfonso F, Gomez-Hospital J, Sabaté M

December 4, 2020 | 10.4244/EIJ-D-20-00198

Coronary interventions

First-in-man randomised comparison of the Angiolite durable fluoroacrylate polymer-based sirolimus-eluting stent versus a durable fluoropolymer-based everolimus-eluting stent in patients with coronary artery disease: the ANGIOLITE trial

Moreu J, Moreno-Gómez R, Pérez de Prado A, García del Blanco B, Trillo R, Pinar E, Molina E, Zueco J, Merchán A, Díaz-Fernández J, Amat I

December 20, 2019 | 10.4244/EIJ-D-19-00206

Coronary interventions

Spain: coronary and structural heart interventions from 2010 to 2015

García del Blanco B, Jimenez-Quevedo P, Diaz J, Hernandez F, Rumoroso J-R, Sabaté M, de la Torre Hernandez J, Serrador A, Pérez de Prado A, Goicolea J, Trillo R, Pan M

May 15, 2017 | 10.4244/EIJ-D-16-00834

Coronary interventions

A randomised trial of paclitaxel-eluting balloon after bare metal stent implantation vs. bare metal stent in ST-elevation myocardial infarction (the PEBSI study)

Garcia-Touchard A, Goicolea J, Sabaté M, Alfonso F, Ruiz-Salmeron R, Bethencourt A, Gonzalo N, Miranda F, García del Blanco B, Jimenez Mazuecos J, Melgares R, Martinez-Romero P, Hernandez-Garcia J, Lezaun R, Bullones J, Fernandez-Portales J, Rumoroso J-R, Ortas R, Valdes M, Trillo R, Brugaletta S, Otzuki S, Hernández Pérez FJ, Alonso-Pulpón L

January 20, 2017 | 10.4244/EIJ-D-16-00128

Rationale and design of the RIBS IV randomised clinical trial (drug-eluting balloons versus everolimus-eluting stents for patients with drug-eluting stent restenosis)

Alfonso F, Pérez-Vizcayno M, Cardenas A, García del Blanco B, García Touchard A, Lopez-Minguez J, Rivero F, Masotti M, Zueco J, Cequier A, Morís C, Fernandez Ortiz A, Escaned J, Jimenez-Quevedo P, Gonzalo N, Fernandez C, Macaya C

July 20, 2015 | 10.4244/EIJY14M09_07

Procedural and early clinical outcomes of patients with de novo coronary bifurcation lesions treated with the novel Nile PAX dedicated bifurcation polymer-free paclitaxel coated stents: results from the prospective, multicentre, non-randomised BIPAX clinical trial

Costa R, Abizaid A, Abizaid An, García del Blanco B, Berland J, Petrov I, Brenot P, van Geuns R, Royer T, Rubino P, Lesiak M, Fajadet J

March 21, 2012 | 10.4244/EIJV7I11A205

Clinical and procedural evaluation of the Nile Croco® dedicated stent for bifurcations: a single centre experience with the first 151 consecutive non-selected patients

García del Blanco B, Martí G, Bellera N, Otaegui I, Serra V, Ferreira I, Domingo E, Angel J, Candell J, García-Dorado D

June 30, 2011 | 10.4244/EIJV7I2A36

1

Latest news

EAPCI/ACVC consensus on pVADs, coronary physiology mini focus, a new analysis from the COAPT trial, patient selection for tricuspid interventions and more…

Treatment of secondary mitral regurgitation in patients with heart failure

Marco Metra et al

This Week's JAA's: DLMC in CTO-PCI, Membranous Septum Morphology and TAVI ...

Coronary flow capacity: where to next?

Nils P. Johnson

Joint EAPCI/ACVC expert consensus document on pVADs

EuroIntervention's new impact factor!

STATE OF THE ART

Completeness of Revascularisation in ACS Patients with Multivessel Disease

Valeria Paradies et al.

Valvular disease